What is a Convertible Note?
February 28, 2022
“Debt or equity?” That is the question many early stage founders face when raising capital.
Larry Bard is a highly regarded business attorney whose clients depend on his guidance in corporate finance and securities law matters, including public and private offerings, venture capital transactions and other financing transactions. He advises companies on issues of corporate governance, business planning, securities law compliance, executive compensation, commercial contracts and complex joint ventures. Larry has completed several initial public offerings for companies in the mid-Atlantic region and has extensive experience in mergers and acquisitions.
Clients across a wide range of industries, including financial, pharmaceutical, technology, biotech and retail, appreciate Larry’s unique blend of experience and expertise, and count on him to thoughtfully work through complex projects. He also works closely with startup and emerging growth companies that are members of NEXT, powered by Shulman Rogers, leveraging the firm’s technology platforms and flexible fee schedules.
A frequent speaker and writer on corporate and securities law, Larry has been recognized as a leading M&A lawyer by Legal 500 and IFLR1000. He formerly clerked for the Delaware Court of the Chancery and the Delaware Supreme Court, and is a certified public accountant.
February 28, 2022
“Debt or equity?” That is the question many early stage founders face when raising capital.
February 28, 2022
“Debt or equity?” That is the question many early stage founders face when raising capital.
July 15, 2021
NEXT powered by Shulman Rogers is proud to have been selected as Startup Firm/Emerging Company Law Firm of the Year by Law.com and Legaltech News in their 2021 Legalweek Leaders in Tech Awards, celebrating the achievements of lawyers and companies leading technology, innovation and the profession as a whole.
October 19, 2020
POTOMAC, MD. October 19, 2020 – Press Ganey recently announced the expansion of its health care consumerism platform with the acquisition of Doctor.com.
June 26, 2020
The NEXT team at Shulman Rogers is proud to have served as counsel to Adaptive Phage Therapeutics, our long-standing client, in establishing an important collaborative relationship with Mayo Clinic Laboratories to commercialize a phage susceptibility test.